#  Shair Group Begins Research Collaboration with Merck  

 





March 31, 2016

 

 

- [ News ](/news-categories/news)
 
 

 

[](http://www.shairlab.com)

Exciting results in the [Shair lab](http://www.shairlab.com) promise both insights into the genetic control of acute myeloid leukemia and a potential treatment. The Shair group’s preclinical work, which had been supported by the Blavatnik Biomedical Accelerator, will now [become a collaboration](http://news.harvard.edu/gazette/story/2016/03/collaboration-to-develop-cancer-therapeutics/) with Merck.



 

 

 



 

 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)